Two analysts have updated their price targets for EXT to $10 - $11. Both are based on discounted cash flow (DCF), assuming that EXT goes to full production. They are not based upon the takeover scenario.
Both have been covering EXT for a while. Their previous price targets were around $8-9. The latest reports Extract have on their website are dated early May, before the recent company announcements. According to Extract updated reports can only be placed on the Extract website 7-10 days after the report is released.
Here is part of the research report from Haywood:
*****************************************
Extract Confirms Rössing South as ‘World-Class’ with a high-grade ‘Maiden’ Inferred Resource at Zone 2: 122 Mlb U3O8 @ 543 ppm
Events: Extract delivers ‘Maiden’ Inferred Resource for Rössing South Zone 2 with spectacular grades that are significantly higher than the Rössing uranium
mine!
Impact – Positive Forecasts, Target Price, Ratings – We have increased our Target Price to A$10.10 from A$8.80 based on new resource estimations by the Company for Zone 2. Our revision uses a DCF of 12 %, and returns a 2014 (FY) production of 9.8 Mlb U3O8 and maximum production to 14.7 Mlb/Yr U3O8 with 2014 (FY) & 2015 (FY) cash costs to US$25 lb-1 U3O8. Estimated 2014(FY) and 2015(FY) CFPS are A$1.74 and A$2.82 respectively. We maintain our SECTOR OUTPERFORM rating and SPECULATIVE risk rating.
- Forums
- ASX - By Stock
- analyst upgrade dcf valuation to $10-11
EXT
excite technology services ltd
Add to My Watchlist
11.1%
!
1.0¢

Two analysts have updated their price targets for EXT to $10 -...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $20.72M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.8¢ | $31.15K | 3.390M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1109800 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1600000 | 0.009 |
6 | 1884688 | 0.008 |
7 | 5270700 | 0.007 |
4 | 2850000 | 0.006 |
2 | 1280000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 1109800 | 3 |
0.011 | 4227645 | 5 |
0.012 | 1982124 | 5 |
0.013 | 314500 | 2 |
0.014 | 1000000 | 1 |
Last trade - 15.23pm 27/06/2025 (20 minute delay) ? |
Featured News
EXT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online